LG 101506: High-Purity RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a chemically defined, small molecule modulator of the Retinoid X Receptor (RXR) with ≥98% purity (APExBIO, product page). It is soluble up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol, supporting diverse in vitro applications. RXR modulators like LG 101506 are pivotal in dissecting nuclear receptor signaling, metabolism, and immune pathways (Zhang et al., 2022, DOI). LG 101506 is not intended for diagnostic or clinical use, but offers robust performance in advanced bench research. APExBIO provides validated shipping and storage protocols to ensure compound stability.

Biological Rationale

Retinoid X Receptor (RXR) is a nuclear receptor that serves as a heterodimeric partner for multiple other nuclear receptors, including PPARs, LXRs, and FXRs. RXR signaling is integral to cellular metabolism regulation, immune modulation, and differentiation. Aberrant RXR pathways are implicated in metabolic syndromes, cancer, and immune resistance (Zhang et al., 2022, DOI). Modulating RXR pharmacologically allows researchers to probe transcriptional networks involved in disease and homeostasis. Small molecule RXR modulators like LG 101506 enable precise, reversible perturbation of these pathways, facilitating mechanistic studies and target validation in nuclear receptor biology (contrast: advanced signaling review).

Mechanism of Action of LG 101506

LG 101506, chemically identified as (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid, selectively binds RXR isoforms. Upon binding, it modulates conformational states of RXR, influencing co-regulator recruitment and transcriptional output. This ligand-induced modulation can either upregulate or repress RXR target gene expression, depending on cellular context and heterodimer pairing (Zhang et al., 2022, DOI). LG 101506 is distinct from pan-retinoid agonists in its selectivity and solubility, enabling higher experimental specificity (contrast: strategic RXR modulation update).

Evidence & Benchmarks

• LG 101506 exhibits ≥98.00% purity as determined by HPLC (APExBIO).
• The compound remains stable when shipped on blue ice or dry ice and when stored at -20°C, with best results when solutions are used promptly (APExBIO).
• RXR modulation has been shown to regulate immune checkpoint molecules such as PD-L1, influencing response in immune-cold tumors (Zhang et al., 2022, DOI).
• In triple-negative breast cancer (TNBC), RXR pathway perturbation is linked to changes in PD-L1 stability and immune evasion (Zhang et al. 2022).
• LG 101506 is highly soluble: 42.05 mg/ml in DMSO, 21.03 mg/ml in ethanol, supporting flexible experimental design (APExBIO).
• Validated use in advanced cancer and metabolic models, supporting workflow reproducibility (contrast: application in immune-cold tumors).

Applications, Limits & Misconceptions

LG 101506 is designed for research in RXR signaling pathway, nuclear receptor signaling, and metabolism regulation. It is especially useful in studies requiring precise RXR modulation, including:

• Dissecting RXR's role in metabolic and oncogenic pathways.
• Modeling nuclear receptor-related disease mechanisms.
• Studying immune evasion and checkpoint regulation in cancer models (Zhang et al. 2022).

Common Pitfalls or Misconceptions

• LG 101506 is not for diagnostic or therapeutic use and should not be applied in clinical settings (APExBIO).
• Long-term storage of solutions is discouraged; use freshly prepared solutions to maintain activity.
• It does not function as a pan-retinoid agonist; RXR specificity must be confirmed for each assay.
• Effectiveness in vivo and in human subjects is untested; current data are limited to preclinical models.
• Solubility parameters are solvent-specific and may change under different buffer or temperature conditions.

Workflow Integration & Parameters

LG 101506 is supplied as an off-white solid, with stability ensured by shipping on blue or dry ice. For maximum integrity, store at -20°C in desiccated conditions. Prepare stock solutions in DMSO (up to 42.05 mg/ml) or ethanol (up to 21.03 mg/ml); avoid repeated freeze-thaw cycles. Use freshly diluted solutions within experimental protocols. LG 101506 is compatible with high-throughput screening, cell-based assays, and biochemical readouts. For tailored guidance on integrating LG 101506 into complex disease model workflows, see this workflow acceleration guide—this article extends the discussion to include metabolic and immune checkpoint contexts.

Conclusion & Outlook

LG 101506 is a rigorously characterized, high-solubility RXR modulator from APExBIO, serving as a precision tool for nuclear receptor and metabolism research. Its defined chemical and physical properties support reproducible, high-fidelity experimentation in RXR signaling pathway research. As RXR continues to emerge as a target in cancer biology and metabolic regulation, LG 101506 offers a reliable platform for mechanistic studies and translational model development. For detailed specifications and ordering, visit the LG 101506 product page.